Delaware Pharmacy Law Sample Question 2

Who shall establish and maintain a PMP program to monitor the prescribing and dispensing of all Schedule II, III, IV and V controlled substances by prescribers in Delaware?

a. The Office of Controlled Substances
b. The Delaware State Pharmacy Board
c. Bureau of Narcotics and Dangerous Drugs
d. ISMP

Who shall establish and maintain a PMP program to monitor the prescribing and dispensing of all Schedule II, III, IV and V controlled substances by prescribers in Delaware?

a. The Office of Controlled Substances
b. The Delaware State Pharmacy Board
c. Bureau of Narcotics and Dangerous Drugs
d. ISMP

Answer: (a), The Office of Controlled Substances, [Uniform Controlled Substances Act 16-47-4798(c)].

The Office of Controlled Substances shall establish and maintain a PMP program to monitor the prescribing and dispensing of all Schedule II, III, IV and V controlled substances by prescribers in this State, and to research the prescribing and dispensing of drugs of concern. The PMP shall not interfere with the legal use of a controlled substance or drug of concern. The PMP shall be:

(1). Used to provide information to prescribers, dispensers, and patients to help avoid the illegal use of controlled substances;

(2). Used to assist law enforcement to investigate illegal activity related to the prescribing, dispensing and consumption of controlled substances or drugs of concern; and

(3). Designed to minimize inconvenience to patients and prescribing medical practitioners while effectuating the collection and storage of prescription monitoring information.